Drug Search Results
More Filters [+]

Chlordiazepoxide

Alternative Names: chlordiazepoxide, librelease, CLORDIAZEPOXIDO, a-poxide, librium, lygen, chlordiazachel, libritabs, librax, menrium 5-2, menrium 10-4, limbitrol ds, menrium 5-4, limbitrol
Latest Update: 2022-03-24
Latest Update Note: Clinical Trial Update

Product Description

Chlordiazepoxide is used to relieve anxiety and to control agitation caused by alcohol withdrawal. Chlordiazepoxide is in a class of medications called benzodiazepines. It works by decreasing abnormal electrical activity in the brain. (Sourced from: https://medlineplus.gov/druginfo/meds/a682078.html)

Mechanisms of Action: GABA Modulator

Novel Mechanism: No

Modality: Small Molecule

Route of Administration: N/A

FDA Designation: None *

Approval Status: Approved

Approved Countries: Argentina | Australia | Bangladesh | Brazil | Bulgaria | Canada | Chile | Colombia | Cyprus | Czech | Denmark | Dominican Republic | Egypt | Finland | France | Germany | Greece | Hong Kong | Hungary | Iceland | India | Indonesia | Ireland | Italy | Jordan | Korea | Latvia | Lebanon | Lithuania | Malaysia | Malta | Morocco | New Zealand | Pakistan | Peru | Poland | Portugal | Russia | Singapore | Slovakia | South Africa | Spain | Taiwan | Thailand | Tunisia | Turkey | United Arab Emirates | United Kingdom | United States | Uruguay | Venezuela | Vietnam

Approved Indications: None

Known Adverse Events: None

Company: None
Company Location:
Company CEO:
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for Chlordiazepoxide

Countries in Clinic:

Active Clinical Trial Count:

Highest Development Phases

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success

Recent News Events

Date

Type

Title